Nucl Med Mol Imaging.  2021 Aug;55(4):186-193. 10.1007/s13139-021-00705-7.

18F-FDG PET/CT Evaluation of Thymomas: a Pictorial Review

Affiliations
  • 1Department of Nuclear Medicine, Seoul National University Hospital, 101, Daehak-ro Jongno-gu, Seoul 03080, South Korea
  • 2Department of Diagnostic Imaging, Fundacion Santa Fe de Bogota University Hospital, Bogota, Colombia
  • 3Department of Radiological Sciences, University of California Medical Center, Irvine, CA, USA
  • 4Department of Medical Oncology, Kyunghee University Medical Center, Seoul, South Korea

Abstract

The World Health Organization classification divides thymomas according to morphology, epithelial component, and cell atypia. They are grouped into 3 large subgroups: low-risk thymomas (types A, AB, and B1), high-risk thymomas (types B2 and B3), and thymic carcinomas. Tumor subtype represents an independent prognostic factor, which determines therapeutic decision. All thymomas show some degree of 18 F-FDG uptake, which tends to increase with the grade of malignancy; this is related to glucose transporter 1 (GLUT1) expression. This review collects all types of thymomas with illustrative images and provides a guide to get familiar with histological characteristics of the lesions and have them in mind because, even imaging findings can overlap among subtypes, certain characteristics can be combined to make an accurate diagnosis based on 18 F-FDG PET-CT findings.

Keyword

Thymic epithelial tumors; Thymomas; 18F-FDG PET-CT; Nuclear medicine; Oncology
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr